Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael; Daniel H. Johnson; Noha Abdel‐Wahab; Wai Chin Foo; Salah-Eddine Bentebibel; May Daher; Cara Haymaker; Khalida Wani; Chantal Saberian; Dai Ogata; Sang T. Kim; Roza Nurieva; Alexander J. Lazar; Hamzah Abu‐Sbeih; Faisal Fa’ak; Antony Mathew; Yinghong Wang; Adewunmi Falohun; Van Trinh; Chrystia M. Zobniw; Christine Spillson; Jared K. Burks; Muhammad O. Awiwi; Khaled M. Elsayes; Luisa M. Solis Soto; Brenda Melendez; Michael A. Davies; Jennifer A. Wargo; Jonathan L. Curry; Cassian Yee; Gregory Lizée; Shalini Singh; Padmanee Sharma; James P. Allison; Patrick Hwu; Sühendan Ekmekçioglu; Adi Diab

doi:10.1016/j.ccell.2022.04.004

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael(The University of Texas MD Anderson Cancer Center), Daniel H. Johnson(Ochsner Health System), Noha Abdel‐Wahab(The University of Texas MD Anderson Cancer Center), Wai Chin Foo(The University of Texas MD Anderson Cancer Center), Salah-Eddine Bentebibel(The University of Texas MD Anderson Cancer Center), May Daher(The University of Texas MD Anderson Cancer Center), Cara Haymaker(The University of Texas MD Anderson Cancer Center), Khalida Wani(The University of Texas MD Anderson Cancer Center), Chantal Saberian(The University of Texas MD Anderson Cancer Center), Dai Ogata(The University of Texas MD Anderson Cancer Center), Sang T. Kim(The University of Texas MD Anderson Cancer Center), Roza Nurieva(The University of Texas MD Anderson Cancer Center), Alexander J. Lazar(The University of Texas MD Anderson Cancer Center), Hamzah Abu‐Sbeih(The University of Texas MD Anderson Cancer Center), Faisal Fa’ak(The University of Texas MD Anderson Cancer Center), Antony Mathew(The University of Texas MD Anderson Cancer Center), Yinghong Wang(The University of Texas MD Anderson Cancer Center), Adewunmi Falohun(The University of Texas MD Anderson Cancer Center), Van Trinh(The University of Texas MD Anderson Cancer Center), Chrystia M. Zobniw(The University of Texas MD Anderson Cancer Center), Christine Spillson(The University of Texas MD Anderson Cancer Center), Jared K. Burks(The University of Texas MD Anderson Cancer Center), Muhammad O. Awiwi(The University of Texas MD Anderson Cancer Center), Khaled M. Elsayes(The University of Texas MD Anderson Cancer Center), Luisa M. Solis Soto(The University of Texas MD Anderson Cancer Center), Brenda Melendez(The University of Texas MD Anderson Cancer Center), Michael A. Davies(The University of Texas MD Anderson Cancer Center), Jennifer A. Wargo(The University of Texas MD Anderson Cancer Center), Jonathan L. Curry(The University of Texas MD Anderson Cancer Center), Cassian Yee(The University of Texas MD Anderson Cancer Center), Gregory Lizée(The University of Texas MD Anderson Cancer Center), Shalini Singh(The University of Texas MD Anderson Cancer Center), Padmanee Sharma(The University of Texas MD Anderson Cancer Center), James P. Allison(The University of Texas MD Anderson Cancer Center), Patrick Hwu(The University of Texas MD Anderson Cancer Center), Sühendan Ekmekçioglu(The University of Texas MD Anderson Cancer Center), Adi Diab(The University of Texas MD Anderson Cancer Center)

Cancer Cell

May 1, 2022

10.1016/j.ccell.2022.04.004

Cited by 336Open Access

Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis